Abhimanyu Roy, the Executive Director at Avalon Consulting, provides insights into precision medicine in India in the August-23 edition of Healthcare Radius magazine.

He emphasizes the global market’s projected growth from $80 billion in 2022 to $168 billion by 2028, with India’s expected value reaching $4.4 billion. According to Abhimanyu, the surge is driven by growing demand, improved accessibility for generic testing, and technological advancements. He adds that precision medicine holds immense potential in identifying and controlling infectious disease outbreaks through genome sequencing, promising a healthier future.